What is the coverage difference between Unasyn (Ampicillin/Sulbactam) and Zosyn (Piperacillin/Tazobactam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

There are no official guidelines to assist in answering this question. I will search for relevant research papers instead.

From the FDA Drug Label

INDICATIONS AND USAGE Piperacillin and Tazobactam for Injection is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: Intra-abdominal infections in adult and pediatric patients 2 months of age and older (1.1) Nosocomial pneumonia in adult and pediatric patients 2 months of age and older (1. 2) Skin and skin structure infections in adults (1.3) Female pelvic infections in adults (1.4) Community-acquired pneumonia in adults (1. 5)

The FDA drug label does not answer the question.

From the Research

Coverage Difference

The coverage difference between Unasyn (Ampicillin/Sulbactam) and Zosyn (Piperacillin/Tazobactam) can be summarized as follows:

  • Unasyn has been shown to be effective against a range of bacteria, including Staphylococcus epidermidis, Staphylococcus aureus, Serratia, Streptococcus, and E. coli 1, 2
  • Zosyn has a broader spectrum of antibacterial activity, encompassing most Gram-positive and Gram-negative aerobic bacteria and anaerobic bacteria, including many pathogens producing beta-lactamases 3
  • A study comparing the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors found that piperacillin/tazobactam (Zosyn) was more active against all Gram-negative species than ampicillin/sulbactam (Unasyn), with the exception of Acinetobacter baumannii 4
  • Another study found that tazobactam-piperacillin (Zosyn) had a broad antibacterial spectrum against Gram-negative and Gram-positive bacteria, and its antibacterial activity was at least 4- to 64-fold stronger than that of piperacillin, clavulanic acid-ticarcillin, and sulbactam-ampicillin against beta-lactamase-producing bacteria 5

Key Findings

  • Zosyn has a broader spectrum of activity against Gram-negative bacteria, including Enterobacteriaceae and Pseudomonas aeruginosa 3, 4
  • Unasyn is effective against Gram-positive bacteria, including Staphylococcus aureus and Streptococcus 1, 2
  • Zosyn is more active against beta-lactamase-producing bacteria than Unasyn 5

Bacterial Coverage

  • Unasyn:
    • Staphylococcus epidermidis
    • Staphylococcus aureus
    • Serratia
    • Streptococcus
    • E. coli
  • Zosyn:
    • Most Gram-positive and Gram-negative aerobic bacteria
    • Anaerobic bacteria
    • Many pathogens producing beta-lactamases, including:
      • Enterobacteriaceae
      • Pseudomonas aeruginosa
      • Acinetobacter baumannii (less active than Unasyn)

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.